This test is most useful if any of these apply to you.
Your body constantly builds and tears down the chemical letters that make up DNA and RNA. When that process runs smoothly, very little uracil ends up in your urine. When it stumbles, whether from a rare metabolic condition, kidney disease, autoimmune activity, or even a recent dietary shift, uracil can spill into your urine in patterns that can be picked up by a lab.
This is a research-grade marker rather than a routine screen. It does not replace a metabolic panel or a kidney workup, but it can flag specific conditions that other tests miss, including a urea cycle disorder that hides behind normal ammonia, and it can track how someone with lupus nephritis is responding to immune-modulating therapy.
Uracil is one of the four chemical letters of RNA and a breakdown product of the pyrimidine pathway, a recycling route your cells use to build and degrade genetic material. Most of the uracil your body produces is destroyed by an enzyme called DPD (dihydropyrimidine dehydrogenase). When that enzyme is impaired, when the urea cycle is disrupted, or when certain disease states alter pyrimidine metabolism, uracil can show up in urine at higher than usual levels.
The lab measures uracil in a urine sample using a technique that separates and identifies small molecules, often as part of an organic acids profile. Because there are no universally accepted clinical cutpoints for this marker in healthy adults, the most useful information comes from tracking your own pattern over time and looking at it in the context of other tests.
In a condition called OTCD (ornithine transcarbamylase deficiency), the body cannot properly process nitrogen, and excess raw material gets diverted into pyrimidine production. Urinary uracil rises as a result, and it can be measured on standard urine organic acid testing using a lab technique that separates and identifies small molecules.
This matters because urinary uracil has identified OTCD in both symptomatic individuals and males who appeared asymptomatic, including cases where ammonia and plasma amino acids looked normal. In other words, it can catch a urea cycle problem that the usual blood-based screens would miss. Urinary uracil also performs as a useful adjunct or alternative to orotic acid, the more traditional marker used in this workup.
In a phase 2 trial of people with lupus nephritis (kidney inflammation from lupus), untargeted urine metabolomics found that uracil and cytosine were elevated at baseline compared with healthy donors. After treatment with anifrolumab, a drug that blocks type I interferon signaling, urine uracil dropped.
The baseline urinary uracil level helped predict who would respond well. People with a baseline urine uracil below the median had a higher chance of achieving a complete renal response on intensive anifrolumab compared with placebo, and the marker added prognostic value beyond standard clinical measures. For someone with lupus nephritis considering this class of therapy, urinary uracil offers information that no routine panel currently captures.
Uracil sits at the intersection of pyrimidine metabolism and kidney function, which is why disordered kidney biology shows up here. A meta-analysis pooling 1,875 cases of diabetic kidney disease against 4,503 controls found that uracil levels were altered in this population, consistent with disrupted pyrimidine handling.
A separate study of plasma extracellular vesicles (tiny packages cells release into blood) found uracil elevated in early diabetic kidney disease, with reasonably good diagnostic performance for distinguishing cases from controls. Combining uracil with three other metabolites improved that prediction further. Uracil and the related molecule pseudouridine have also been linked to progression toward end-stage kidney disease. These findings came from plasma rather than urine, so they are biologically related but not direct evidence about urinary uracil specifically.
Urinary uracil is chemically unstable and highly sensitive to how a sample is collected, stored, and processed. Time and temperature can shift the measurement. This means a single result, especially an unexpected one, deserves a repeat test before any conclusion is drawn.
Diet also moves the number. In a small study of 14 healthy volunteers, dietary lemon intake produced a significant decrease in urinary uracil and altered other pyrimidine pathway markers in morning urine. That is a real biological shift, but it illustrates that everyday choices can influence what shows up. The most useful approach is to establish a baseline, then retest in 3 to 6 months if you are making changes that might affect the pathway, and at least annually if you are tracking a specific condition like lupus nephritis or a known metabolic disorder.
An elevated urinary uracil does not have a single interpretation. The right next step depends on the context. If you have no symptoms and a normal metabolic panel, a repeat sample with careful handling is the first move. If the second test confirms the finding, the pattern of other organic acids in the same panel matters. Elevated orotic acid alongside elevated uracil points toward a urea cycle workup, which typically involves a metabolic geneticist or endocrinologist. Elevated uracil with markers of kidney injury points toward a nephrology evaluation.
For someone with lupus nephritis already in treatment, a falling urinary uracil over serial measurements can be a useful supporting signal that immune-targeted therapy is working, alongside the standard markers your rheumatologist or nephrologist follows. For most other readers, the most actionable use of this test is as a baseline to compare against future samples, especially if you have a family history of metabolic disease or you are exploring why other tests have come back ambiguous.
Standardized reference ranges for urinary uracil in healthy adults do not yet exist. The strongest evidence supports its use in specific clinical scenarios (urea cycle disorder workup, lupus nephritis treatment response, kidney disease research) rather than as a general screen. That does not mean it is uninformative. It means a single reading should not drive a major decision in isolation. Tracking your own number, and pairing it with other tests that have established cutpoints, is how this marker delivers the most value today.
Evidence-backed interventions that affect your Uracil level
Uracil is best interpreted alongside these tests.
Uracil is included in these pre-built panels.